Brought to you by the CAR-TCR Digital Week, in partnership with Lonza
During this round table digital event, a panel of experts shares insights when evaluating and advancing cell therapies from translation to the clinical trials and beyond. The moderator focuses the discussion on current and future trends along with evaluating technology platforms, raw materials, and manufacturing challenges. The session closes with a discussion of how to better meet these challenges within this rapidly evolving space.
Panelists
Dr. Laurence Cooper
CEO, Ziopharm Oncology, Inc.
Boston, MA, USA
Dr. Isabelle Riviere
Director Cell Therapy and Cell Engineering Facility
Memorial Sloan Kettering Cancer Center
New York, NY, USA
Dr. Steve Feldman
Director of Manufacturing and Process Development
Center for Cancer Cell Therapy, Stanford University
Stanford, CA, USA
Dr. Eytan Abraham
Head of Personalized Medicine
Lonza Pharma&Biotech
Walkersville, MD, USA
Discover how Lonza can support your path from discovery to commercialization
